Resistance mutations found in those receiving GSK and Vir's monoclonal for Delta, new research shows - Endpoints News

While the Delta variant is in the rearview mirror now, new research from Australia shows how some people developed sotrovimab-resistant mutations following infusions with the GlaxoSmithKline and Vir monoclonal antibody when they were sick with Covid-19. The m…

While the Delta variant is in the rearview mirror now, new research from Australia shows how some people developed sotrovimab-resistant mutations following infusions with the GlaxoSmithKline and Vir … [+3337 chars]

full article...